Key result
Deferred PCI and staged antithrombotics safely resolve symptoms in concurrent ACS, PE, and gastric cancer.
Why the study?
Concurrent acute coronary syndrome and pulmonary embolism is rare and presents significant diagnostic and therapeutic challenges, particularly in patients with underlying malignancy.
Case Report (n=1)
No
This case demonstrates the successful multidisciplinary management of concurrent acute coronary syndrome and pulmonary embolism in a patient with active gastrointestinal malignancy using a staged procedural approach and an individualized antithrombotic strategy.
Prompts heightened suspicion for concurrent ACS and PE in malignancy; leaves open optimal diagnostic and therapeutic pathways.
Acute coronary syndrome (ACS) and pulmonary embolism (PE) are common, potentially life-threatening causes of acute chest pain with significant clinical overlap. Their concurrent occurrence is rare and presents important diagnostic and therapeutic challenges, particularly in patients with underlying malignancy. We report a case of a male in his 50s who presented with a two-week history of exertional chest pain and dyspnoea. Initial symptoms were attributed to iron deficiency anaemia, and subsequent outpatient investigation identified a type 1 gastric neuroendocrine tumour. He later re-presented with persistent symptoms, and further evaluation revealed bilateral pulmonary emboli and significant coronary artery disease (CAD). Management was particularly challenging given the competing risks of thrombosis and haemorrhage in the setting of active gastrointestinal malignancy. Following a multidisciplinary team discussion, percutaneous coronary intervention (PCI) was deferred until after tumour resection to mitigate bleeding risk. Following PCI, an individualised antithrombotic regimen was implemented to balance early stent protection with longer-term bleeding risk. This case demonstrates the challenges of diagnosing and managing concurrent ACS and PE in patients with gastric malignancy, highlighting the need for an individualised, multidisciplinary approach.
No takes yet. Share an insight, caveat, or question.
Turnbull et al. (2026) conducted a case report in Concurrent Acute Coronary Syndrome, Pulmonary Embolism, and Gastric Malignancy (n=1). Deferred percutaneous coronary intervention (PCI) and individualized antithrombotic therapy was evaluated on Resolution of symptoms without thrombotic or haemorrhagic complications. Deferred percutaneous coronary intervention followed by an individualized, staged antithrombotic regimen successfully resolved chest pain and dyspnoea in a patient with concurrent acute coronary syndrome, pulmonary embolism, and gastric malignancy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: